https://ir.imux.com/ https://ir.imux.com/2026-06-10-Immunic-to-Participate-in-Investor,-Industry-and-Scientific-Conferences-in-June Wed, 10 Jun 2026 06:30:00 -0400 https://ir.imux.com/2026-06-10-Immunic-to-Participate-in-Investor,-Industry-and-Scientific-Conferences-in-June https://ir.imux.com/2026-05-28-Immunic-to-Present-Additional-Phase-2-CALLIPER-Trial-Data-for-Vidofludimus-Calcium-at-the-CMSC-Annual-Meeting-2026,-Reinforcing-Its-Potential-in-Progressive-Multiple-Sclerosis Thu, 28 May 2026 06:30:00 -0400 https://ir.imux.com/2026-05-28-Immunic-to-Present-Additional-Phase-2-CALLIPER-Trial-Data-for-Vidofludimus-Calcium-at-the-CMSC-Annual-Meeting-2026,-Reinforcing-Its-Potential-in-Progressive-Multiple-Sclerosis https://ir.imux.com/2026-05-27-Immunic-Appoints-Distinguished-Biopharmaceutical-Executive-Erik-Lundgren-as-Chief-Executive-Officer Wed, 27 May 2026 06:30:00 -0400 https://ir.imux.com/2026-05-27-Immunic-Appoints-Distinguished-Biopharmaceutical-Executive-Erik-Lundgren-as-Chief-Executive-Officer https://ir.imux.com/2026-05-19-Immunic-Appoints-Seasoned-Biopharmaceutical-Executive-Michael-W-Bonney-as-Chair-of-the-Board-of-Directors Tue, 19 May 2026 06:30:00 -0400 https://ir.imux.com/2026-05-19-Immunic-Appoints-Seasoned-Biopharmaceutical-Executive-Michael-W-Bonney-as-Chair-of-the-Board-of-Directors https://ir.imux.com/2026-05-13-Immunic,-Inc-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update Wed, 13 May 2026 06:30:00 -0400 https://ir.imux.com/2026-05-13-Immunic,-Inc-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update